Trial Condition(s):

Erectile Dysfunction

Evaluation of efficacy and safety of Vardenafil in patients with erectile dysfunction and type 1 diabetes

Bayer Identifier:

100540

ClinicalTrials.gov Identifier:

NCT00660998

EudraCT Number:

Not Available

Study Completed

Trial Purpose

Asses efficacy of Vardenafil in patients with type 1 diabetes and erectile dysfunction

Inclusion Criteria
- Men >/= 18 years of age, with 6 months or longer diagnosis of ED as defined by NIH Consensus statement,
 - Diabetes type 1
 - Stable sexual relationship for > 6 month.
Exclusion Criteria
- Primary hypoactive sexual desire
 - History of myocardial infarction, stroke or life-threatening arrhythmia within prior 6 month
 - Nitrate therapy

Trial Summary

Enrollment Goal
318
Trial Dates
black-arrow
Phase
4
Could I receive a placebo?
Yes
Products
Levitra (Vardenafil, BAY38-9456)
Accepts Healthy Volunteers
No

Where to Participate

Loading...
Locations
Status
LocationsStatus
Locations

Investigative Site

Many locations, Germany

Status
Completed
 

Trial Design